Asia Pacific Sterility Testing Market Size, Segmentation Analysis by Type, Product, Test, Application, Region and Forecast, 2023-2029

Asia Pacific Sterility Testing Market size was valued at USD 240 Mn. in 2022 and the total Sterility Testing revenue is expected to grow by 10.25 % from 2023 to 2029, reaching nearly USD 475.18 Mn.
Asia Pacific Sterility Testing Market Overview:
A sterility test is one of the importantstages in the manufacturing process and ensures the absence of any viable microorganisms such as viruses or bacteria.The Asia-Pacific region has emerged as a major healthcare sector, expected rapid growth in the pharmaceutical, biotechnology, and medical device industries. Technological advancements in sterility testing are done by market leaders like Auriga Research Pvt Ltd., Steris Ast, Eurofins BioPharma and Samsung Biologicswhich offers a wide range of sterility testing services.

Research Methodology and Scope:

The Asia Pacific Sterility Testing Market report provides an in-depth analysis of sales channels, distributors, growth drivers, challenges, trends, opportunities, risks, and entry barriers. The Market report utilizes a research methodology involving the analysis of literature, industry releases, annual reports, and relevant documents from key industry participants.


To know about the Research Methodology :- Request Free Sample Report
Asia Pacific Sterility Testing Market Dynamics:
Drivers:

Increased Strict quality regulations drive the Market

Regulatory authorities in the APAC region, such as the China National Medical Products Administration (NMPA), Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, and the Central Drugs Standard Control Organization (CDSCO) in India, have implemented strict regulations regarding sterility testing in the formulation process of all pharmaceutical’s products including drugs, vaccines, medical devices and point of care detection kits. Compliance with these regulations, Sterility Testing is important for market entry, fostering the demand for sterility testing services. Increased Strict quality regulations are expected to drive the Market growth.

Restraints:

Escalating Cost of Sterility Testing Pose Challenges to the Sterility Testing Market

Growing demand for Sterilized medical devices and drugs in the healthcare domain, the cost of sterilization is expensive, which limits the growth among certain segments of the market. The sterility testing market encounters multiple constraints that inhibit the sterility testing market growth and expansion. The rise in the unit price of sterility testing is a major factor, making it more costly for companies to conduct these tests. This, coupled with a scarcity of qualified professionals in the field of sterility testing, further hinders the Sterility Testing Market growth.

Opportunities:

Establishment of Medical Infrastructures Offers Greater Opportunity for Sterility Testing Market

The number of medical facilities opening in APAC is expected to offer a better opportunity to increase the demand for sterilised equipment. With the expansion of the healthcare infrastructure, the need for efficient and reliable Sterility Testing becomes increasingly important, which, in turn, directly impacts the growth of the sterility testing market globally. Sterility Testing Market growth will be assisted by government initiatives for instance, the 'Production Linked Incentive (PLI) Scheme (INDIA) for Medical Devices and the establishment of medical infrastructures, which provide a greater opportunity for the growth of the Sterility Testing industry.
Asia Pacific Sterility Testing Market Segmentation:
Based on Type,Outsourcing Sterility Testing dominated the market with the highest market share in 2022. The segment is further expected to grow at a distinct CAGR and maintain its dominance by 2029 thanks to advanced technology used in outsourcing sterility testing services. While In-houseSterility Testing is expected to grow during the forecast period as startups in healthcare services are vigorously increasing in the APAC region specifically in India and China because the cost of outsourcing the service is not affordable to startups.


Regional Analysis:
Based on region Market is segmented into China, India, Japan, South Korea, Malaysia and Rest of the Asia Pacific Region. APAC is the fastest-growing market for sterility testing thanks to medical advancements from leading countries like China and India, and outsourcing medicines and vaccines gave rise to the sterility testing market. The growth of the sterility testing market is followed by Japan and the rest of the Asia Pacific countries.


Competitive Landscape:
Asia Pacific Sterility Testing Market is highly competitive thanks to technological advancements in developing countries like India and China, with the presence of both global and local players. Key companies operating in the market include Auriga Research, STERIS AST, Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., and Samsung Biologics Co., Ltd which are continuously doing technological advancements in healthcare services.
Asia Pacific Sterility Testing Market Scope: Inquire before buying



Asia Pacific Sterility Testing Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2021
Market Size in 2022:
US $ 240Mn.


Forecast Period 2023 to 2029 CAGR:
10.25 %
Market Size in 2029:
US $ 475.18 Mn.


 Segments Covered:
by Type
1. In-house
2. Outsourcing


by Product
1. Kits and Reagents
2. Instruments
3. Other


by Test
1. Membrane Filtration
2. Direct Inoculation
3. Container Closure Integrity Test
4. Rapid Micro Test


by Application
1. Pharmaceutical Manufacturing
2. Medical Device Manufacturing
3. Research Organizations
4. Other Applications



Key Players:
1. Aurigaresearch
2. STERIS AST
3. Thermo Fisher Scientific, Inc.
4. Charles River Laboratories International, Inc.
5. SGS S.A.
6. WuXi AppTec Co., Ltd.
7. Sartorius AG
8. Samsungbiologics Co., Ltd. (Samsung Group)
9. Nelson Laboratories, LLC (Sotera Health Company)
10. Pacific Biolabs, Inc.

FAQ:
1. What is the projected market size of the Market in 2029?
Ans. The Asia Pacific Sterility Testing Market size is expected to reach US$ 475.18 Mn in 2022.

2. What segments are covered in the Market report?
Ans. The segments covered are Type, Product, Test, Application and region.

3. What is the forecast period for the Market?
Ans. The forecast period for the Asia Pacific Sterility Testing Market is 2022-2029.

4. What was the market size of the Market in 2022?
Ans. The market size of the Asia Pacific Sterility Testing Market in 2022 was valued at US$ 240 Mn.

5. Which region is expected to hold the highest share in the Market?
Ans. China is expected to hold the highest share of the Asia Pacific Sterility Testing Market.